🇺🇸 FDA
Patent

US 12263145

Methods of administering solriamfetol to lactating women

granted A61KA61K31/138A61K31/165

Quick answer

US patent 12263145 (Methods of administering solriamfetol to lactating women) held by AXSOME MALTA LTD. expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AXSOME MALTA LTD.
Grant date
Tue Apr 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/138, A61K31/165